-       Drug Pipelines 
- June 2025
-  200 Pages 
- Global 
   From       €2482EUR$2,789USD£2,185GBP 
          -       Report 
- June 2025
-  400 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- June 2025
-  400 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- September 2025
-  72 Pages 
- Global 
   From       €3500EUR$4,213USD£3,189GBP 
          -       Report 
- May 2025
-  87 Pages 
- Global 
   From       €3500EUR$4,213USD£3,189GBP 
           -       Report 
- January 2025
-  120 Pages 
- Global 
        €4990EUR$6,007USD£4,546GBP 
          -       Report 
- September 2025
-  261 Pages 
- United States 
   From       €1646EUR$1,850USD£1,449GBP 
          -       Report 
- August 2025
-  200 Pages 
- United States 
   From       €2216EUR$2,490USD£1,950GBP 
          -       Report 
- February 2020
-  360 Pages 
- Global 
   From       €4359EUR$4,899USD£3,837GBP 
            -       Report 
- May 2024
-  420 Pages 
- Global 
   From       €2136EUR$2,400USD£1,880GBP 
      €2670EUR$3,000USD£2,350GBP 
            -       Report 
- December 2023
-  220 Pages 
- Global 
   From       €2349EUR$2,640USD£2,068GBP 
      €2937EUR$3,300USD£2,585GBP 
            -       Drug Pipelines 
- August 2023
-  400 Pages 
- China 
   From       €2136EUR$2,400USD£1,880GBP 
      €2670EUR$3,000USD£2,350GBP 
            -       Report 
- June 2022
-  1500 Pages 
- Global 
   From       €2776EUR$3,120USD£2,444GBP 
      €3470EUR$3,900USD£3,055GBP 
            -       Drug Pipelines 
- March 2022
-  900 Pages 
- Global 
   From       €6407EUR$7,200USD£5,640GBP 
      €8009EUR$9,000USD£7,050GBP 
          -       Report 
- September 2024
-  120 Pages 
- China 
   From       €5295EUR$5,950USD£4,661GBP 
          -       Report 
- May 2024
-  150 Pages 
- Global 
   From       €5295EUR$5,950USD£4,661GBP 
          -       Report 
- January 2023
-  189 Pages 
- Global 
   From       €3737EUR$4,200USD£3,290GBP 
          -       Report 
- April 2021
- China 
   From       €2314EUR$2,600USD£2,037GBP 
          -       Report 
- May 2024
-  200 Pages 
- Global 
   From       €3693EUR$4,150USD£3,251GBP 
          -       Report 
- January 2024
-  200 Pages 
- Global 
   From       €3693EUR$4,150USD£3,251GBP 
       
      Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is    also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body.
PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less   Read more